β-alanine in the Treatment of Advanced Hepatocellular Carcinoma

Clinical trial NCT07317414 · RECRUITING

Trial details

NCT number: NCT07317414
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2025-12-24
Primary completion: 2028-12-05
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.